vs
Side-by-side financial comparison of Genius Sports Ltd (GENI) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $493.8M, roughly 1.0× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -12.3%, a 19.2% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs -0.1%).
Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
GENI vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $510.9M | $493.8M |
| Net Profit | $-63.0M | $33.7M |
| Gross Margin | 25.2% | — |
| Operating Margin | -11.5% | 9.9% |
| Net Margin | -12.3% | 6.8% |
| Revenue YoY | — | -1.7% |
| Net Profit YoY | — | 10.5% |
| EPS (diluted) | — | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $510.9M | $493.8M | ||
| Q3 25 | $335.4M | $492.9M | ||
| Q2 25 | $215.2M | $468.8M | ||
| Q1 25 | $119.7M | $458.4M | ||
| Q4 24 | $413.0M | $502.4M | ||
| Q3 24 | $285.8M | $511.2M | ||
| Q2 24 | $184.1M | $504.3M | ||
| Q1 24 | $97.2M | $495.1M |
| Q4 25 | $-63.0M | $33.7M | ||
| Q3 25 | — | $71.7M | ||
| Q2 25 | $-47.3M | $39.3M | ||
| Q1 25 | $-25.5M | $20.7M | ||
| Q4 24 | $-85.5M | $30.5M | ||
| Q3 24 | $-47.1M | $19.4M | ||
| Q2 24 | $-35.5M | $-153.0M | ||
| Q1 24 | $-25.2M | $4.0M |
| Q4 25 | 25.2% | — | ||
| Q3 25 | 24.2% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | 16.7% | — | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 18.6% | — | ||
| Q1 24 | 9.8% | — |
| Q4 25 | -11.5% | 9.9% | ||
| Q3 25 | -15.3% | 13.8% | ||
| Q2 25 | -21.0% | 12.8% | ||
| Q1 25 | -20.3% | 7.0% | ||
| Q4 24 | -18.0% | 7.8% | ||
| Q3 24 | -13.9% | 6.6% | ||
| Q2 24 | -16.8% | -31.3% | ||
| Q1 24 | -23.7% | 3.2% |
| Q4 25 | -12.3% | 6.8% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | -22.0% | 8.4% | ||
| Q1 25 | -21.3% | 4.5% | ||
| Q4 24 | -20.7% | 6.1% | ||
| Q3 24 | -16.5% | 3.8% | ||
| Q2 24 | -19.3% | -30.3% | ||
| Q1 24 | -25.9% | 0.8% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.23 | ||
| Q2 24 | — | $-1.84 | ||
| Q1 24 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $280.6M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $724.5M | $865.9M |
| Total Assets | $1.1B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $280.6M | $375.2M | ||
| Q3 25 | $110.2M | $340.1M | ||
| Q2 25 | $110.2M | $224.7M | ||
| Q1 25 | $110.2M | $99.0M | ||
| Q4 24 | $100.3M | $229.9M | ||
| Q3 24 | $100.3M | $103.8M | ||
| Q2 24 | $100.3M | $19.4M | ||
| Q1 24 | $100.3M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $724.5M | $865.9M | ||
| Q3 25 | $572.4M | $890.7M | ||
| Q2 25 | $572.4M | $833.8M | ||
| Q1 25 | $572.4M | $789.2M | ||
| Q4 24 | $573.0M | $764.9M | ||
| Q3 24 | $573.0M | $732.5M | ||
| Q2 24 | $573.0M | $706.5M | ||
| Q1 24 | $573.0M | $856.2M |
| Q4 25 | $1.1B | $2.2B | ||
| Q3 25 | $792.3M | $2.2B | ||
| Q2 25 | $792.3M | $2.1B | ||
| Q1 25 | $792.3M | $2.0B | ||
| Q4 24 | $775.7M | $2.2B | ||
| Q3 24 | $775.7M | $2.1B | ||
| Q2 24 | $775.7M | $2.0B | ||
| Q1 24 | $775.7M | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $81.9M | $114.1M |
| Free Cash FlowOCF − Capex | $69.6M | — |
| FCF MarginFCF / Revenue | 13.6% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $33.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.9M | $114.1M | ||
| Q3 25 | $-4.8M | $137.3M | ||
| Q2 25 | $-1.2M | $137.2M | ||
| Q1 25 | $-14.6M | $-117.5M | ||
| Q4 24 | $14.9M | $133.0M | ||
| Q3 24 | $-9.2M | $91.8M | ||
| Q2 24 | — | $107.0M | ||
| Q1 24 | — | $-125.2M |
| Q4 25 | $69.6M | — | ||
| Q3 25 | $-14.2M | — | ||
| Q2 25 | $-5.8M | — | ||
| Q1 25 | $-16.0M | — | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $-11.6M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 13.6% | — | ||
| Q3 25 | -4.2% | — | ||
| Q2 25 | -2.7% | — | ||
| Q1 25 | -13.4% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | -4.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GENI
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
